However, taking 300 mg/d or 100 mg/BID is more effective than taking 100 mg/d in acetylating COX-1, reducing TXB2 levels, and restraining tumor-promoting gene expression in CRC tissue. The gene discussed is PTGS1; the disease is neoplasm.